Found 19 matching trials
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients PHASE4 The objective of the study is to compare the cardiovascular profile of an e...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation PHASE2 The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Show More Location
University of Alabama
Learn More & Join Trial
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) PHASE4 Protocol Title: Randomized open label study comparing the metabolic control...
Show More Location
Stanford university Hospital and Clinics
Learn More & Join Trial
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients PHASE2 This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation PHASE2 The primary objective of the trial is to evaluate efficacy and safety of de...
Show More Location
Regensburg University Hospital
Learn More & Join Trial
Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity. PHASE4 The objective is to assess if low pre-transplantation donor specific T-cell...
Show More Location
Nephrology Department. Hospital Vall d'Hebró
Learn More & Join Trial
Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation PHASE4 Clinical Problem: Renal insufficiency after heart transplantation caused by...
Show More Location
Medizinische Universitätsklinik, Kardiologie
Learn More & Join Trial
Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation PHASE1 Our final objective is to develop an adoptive therapy with tolerogenic dono...
Show More Location
IRCCS San Raffaele Scientific Institute
Learn More & Join Trial
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NA Long-term outcomes in kidney transplantation remain a significant challenge...
Show More Location
Service de Néphrologie-Transplantation-Dialyse I Hôpital Pellegrin I - CHU Bordeaux
Learn More & Join Trial
Regimen Optimization Study PHASE2 Patients who undergo a kidney transplant require prolonged therapy with dru...
Show More Location
California Institute Of Renal Research
Learn More & Join Trial